Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
Clinical trial NCT05598151 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05598151
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-11
- Primary completion
- 2028-01-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.